Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
- Status
- TERMINATED
- Phase
- NA
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013)
- Status
- COMPLETED
- Phase
- PHASE1
Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention
- Status
- COMPLETED
- Phase
- PHASE3
Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Revlimid® (Lenalidomide) With Mabthera® (Rituximab) in Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL
- Status
- UNKNOWN
- Phase
- PHASE2
Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms
- Status
- TERMINATED
- Phase
- PHASE1
Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- Status
- RECRUITING
- Phase
- PHASE1
Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE3
Unrelated Umbilical Cord Blood (UBC)Transplantation
- Status
- COMPLETED
- Phase
- NA
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat Non-Hodgkin's Lymphoma (NHL)
- Status
- COMPLETED
- Phase
- PHASE2
Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR
- Status
- COMPLETED
- Phase
- NA